Ingredient or product comparison
GHK-Cu vs Minoxidil Hair Growth Comparison
Primary Mechanism Follicle stem cell activation, collagen synthesis, TGF-beta modulation Vasodilation, potassium channel opening, anagen phase prolongation GHK-Cu addresses structural causes; minoxidil treats cycle symptoms Hair Density Improvement (24 weeks)
This source-based comparison does not add ratings or recommend a winner.
- Primary Mechanism
- Follicle stem cell activation, collagen synthesis, TGF-beta modulation
- Vasodilation, potassium channel opening, anagen phase prolongation
- GHK-Cu addresses structural causes; minoxidil treats cycle symptoms
- Hair Density Improvement (24 weeks)
- 11–15% increase in clinical trials
- 14–18% increase in clinical trials
- Minoxidil edges slightly higher in density; both statistically significant
- Hair Shaft Diameter Change
- 9–12% increase (significant thickening of miniaturized hairs)
- 2–4% increase (minimal effect on diameter)
- GHK-Cu superior for reversing miniaturization
- Effect Persistence After Discontinuation
- Partial retention 8–12 weeks (structural improvements decay slowly)
- Complete reversal within 90–120 days (growth cycle dependent)
- GHK-Cu provides longer residual benefit post-treatment
- Application Frequency
- Once daily (longer formulation stability with encapsulation)
- Twice daily (short half-life requires consistent dosing)
- GHK-Cu less burdensome for adherence
- Side Effect Incidence
- <1% (mild irritation, no systemic effects documented)
- 4–7% contact dermatitis, 2–3% systemic (tachycardia, hypertrichosis)
- GHK-Cu significantly safer profile
- FDA Approval Status
- Not FDA-approved as a drug (available as cosmetic ingredient)
- FDA-approved for androgenetic alopecia (OTC 2%, 5% Rx)
- Minoxidil has regulatory approval; GHK-Cu lacks formal drug status
- Cost (Monthly Supply)
- $45–$85 for research-grade 0.05–0.1% serum
- $15–$35 for brand/generic 5% solution or foam
- Minoxidil substantially more affordable at retail
- Combination Synergy
- Highly compatible (alternating application avoids interaction)
- Compatible with peptides, finasteride, microneedling
- Both integrate well into multi-agent protocols
- Bottom Line
- Best for patients prioritizing hair quality, diameter restoration, and structural follicle health with lower side effect tolerance
- Best for patients seeking maximum density gain, FDA-approved treatment, and cost-effectiveness despite twice-daily application
- Choose GHK-Cu if miniaturization and dermal thinning dominate; choose minoxidil if cycle prolongation and density are primary goals